Saint-Priez en Jarez, France Clinical Trials

A listing of Saint-Priez en Jarez, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
Study of Irinotecan Liposome Injection (ONIVYDE ) in Patients With Small Cell Lung Cancer

A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection (ONIVYDE) versus Topotecan in Patients with Small Cell Lung Cancer Who Have Progressed on or after Platinum-based First-Line Therapy The study will be conducted in two parts: Dose determination of irinotecan liposome injection A randomized, efficacy study of irinotecan …

renal function test
carboplatin
irinotecan
topotecan
H pital de la Timone
 (157.6 away) Contact site
  • 603 views
  • 02 Nov, 2020
  • +209 other locations
Evaluation of a Marine OXYgen Carrier for Organ Preservation

Preventing ischemia/reperfusion injuries (IRIs) is a major issue in kidney transplantation, particularly for transplant recipients receiving a kidney from extended criteria donors (ECD). The main consequence of IRIs is delayed graft function (DGF). The medical device HEMO2life, an oxygen carrier developed by the Hemarina French Company, is a natural extracellular …

Saint-Etienne
 (2.4 away) Contact site
  • 0 views
  • 26 Jul, 2020
  • +21 other locations
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this program is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

fistulising crohn's disease
colitis
ileocolitis
ustekinumab
endoscopy
CHU Saint-etienne
 (2.4 away) Contact site
  • 792 views
  • 05 Nov, 2020
  • +750 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
CHU de SAINT ETIENNE - Hopital Nord /ID# 171580
 (0.5 away) Contact site
  • 604 views
  • 05 Nov, 2020
  • +616 other locations
Nivolumab With Gemcitabine Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

This study evaluates the addition of nivolumab to gemcitabine, oxaliplatin plus rituximab in case of B-cell lymphoma

cell transplantation
hodgkin's disease
rituximab
b-cell lymphoma
aggressive non-hodgkin's lymphoma
Institut de Canc rologie Lucien Neuwirth
 (0.0 away) Contact site
  • 234 views
  • 10 Sep, 2020
  • +122 other locations
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis (UC).

medical therapy
CHU Saint-Etienne - H pital Nord
 (0.5 away) Contact site
  • 226 views
  • 05 Nov, 2020
  • +445 other locations
TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

A 3-Year Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects with Ulcerative Colitis who have participated in the Maintenance Study of Protocol 0157

remission
Theravance Biopharma Investigational Site
 (2.4 away) Contact site
  • 7 views
  • 17 Sep, 2020
  • +144 other locations
Efficacy & Safety of TD-1473 in Ulcerative Colitis

A Phase 2b/3 set of studies to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473 in subjects with moderately-to-severely active ulcerative colitis with up to 60 weeks of treatment.

corticosteroids
aminosalicylates
immunomodulators
Theravance Biopharma Investigational Site
 (2.4 away) Contact site
  • 75 views
  • 26 Oct, 2020
  • +198 other locations
Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours

Bile duct tumours are rare. They are the 6th most common type of digestive cancer. Their therapeutic management is complex and must be multidisciplinary in nature. Most of the time, an endoscopic or radiological biliary drainage is necessary before any tumour treatment. Their prognosis is poor due to the fact …

prothrombin
neutrophil count
drainage
folfirinox
gemcitabine
CHU Saint-Etienne
 (2.4 away) Contact site
  • 37 views
  • 02 Feb, 2020
  • +41 other locations